In The News: February 2012

In the first study of its kind to demonstrate an association between the antidepressant escitalopram and improved general pain, researchers from Boston University School of Medicine found that opioid-dependent patients treated with escitalopram experienced significant reductions in pain during the first three months of therapy. More than 600 patients addicted to prescription opioids were randomized to receive 10 mg of escitalopram or a placebo daily. Changes in pain severity and depression were assessed at one, two, and three months. Investigators found that treatment with escitalopram resulted in a meaningful reduction in pain over time, with nearly 30 percent reduction in pain after just one month compared to the control group.
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Arthritis Advisor

Get the next year of Arthritis Advisor for just $20. And access all of our online content - over 1,000 articles - free of charge.
Subscribe today and save 36%. It's like getting 4 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access